Concepedia
Statistics
Publications
17
Citations
650
H-Index
15
Active since
1997
Affiliations
Karolinska Institutet(Current)
Karolinska University Hospital
Industrial University of Santander
Nanjing Medical University
Swedish Veterinary Agency
Anna Berglöf is an author at Karolinska Institutet specializing in bruton tyrosine kinase, life sciences, and immunology.
Publications per year
1997–2024
The transcriptional regulator PLZF induces the development of CD44 high memory phenotype T cells
Julia Raberger, Alexandra Schebesta, Shinya Sakaguchi et al. · Proceedings of the National Academy of Sciences · 2008 · 79 citations · Full text
Life Sciences, Cell Biology, Immunology +17
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib
H. Yesid Estupiñán, Qing Wang, Anna Berglöf et al. · Leukemia · 2021 · 73 citations · Full text
Medicine, Oncology, Pharmacology +14
Functional Interaction of Caveolin-1 with Bruton's Tyrosine Kinase and Bmx
Leonardo Vargas, Beston F. Nore, Anna Berglöf et al. · Journal of Biological Chemistry · 2002 · 63 citations · Full text
Life Sciences, Biochemistry, Immunology +12
Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant
Abdulrahman Hamasy, Q. Wang, K. Emelie M. Blomberg et al. · Leukemia · 2016 · 58 citations · Full text
Medicine, Oncology, Pharmacology +15
Lindvall, J. M. et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol. Rev. 203, 200-215
Jessica M. Lindvall, Jouni Väliaho, K. Emelie M. Blomberg et al. · 2005 · 53 citations
Life Sciences, Immunology, Molecular Biology +15
1–5 of 17